Ginkgo Bioworks acquires Proof Diagnostics to boost cell programming and biosecurity capabilities
Ginkgo Bioworks, a leader in cell programming and biosecurity, announced its acquisition of Proof Diagnostics, a trailblazer in life sciences tools, diagnostics, and computational discovery. ... Read More
Ginkgo Bioworks acquires Reverie Labs’ AI/ML assets to revolutionize biosecurity and drug discovery
In a strategic move to solidify its position as a leader in cell programming and biosecurity, Ginkgo Bioworks Holdings, Inc. (NYSE: DNA) has announced the ... Read More
Ginkgo Bioworks to acquire fungal platform firm Dutch DNA Biotech
Ginkgo Bioworks has agreed to acquire Dutch DNA Biotech, a Netherlands-based company focused on developing fungal strains and fermentation processes for producing proteins and organic ... Read More
US biotech company Ginkgo Bioworks to merge with Soaring Eagle in $15bn deal
Ginkgo Bioworks, a Boston-based biotech company, has agreed to merge with Soaring Eagle Acquisition Corp., a publicly traded blank check company, in a deal that ... Read More